Top

Litigation Update: Time to Round Up Roundup?

Posted on 11/06/2019Back

The link between the popular weed killer Roundup and cancer became public in 2015 when the International Agency for Research on Cancer (IARC)—the agency devoted to cancer research within the World Health Organization—released a report exposing the connection between Roundup’s active ingredient glyphosate and cancer.

Since the IARC released this report, thousands of Roundup users have tied their diagnoses of Non-Hodgkin’s Lymphoma to Roundup exposure and taken legal action.

What Is Happening With The Roundup Litigation?

As of November 2019, analysts project that there are more than 45,000 Roundup plaintiffs in the United States. That number stands in sharp contrast to Bayer AG’S July 2019 estimate of 18,400.

Bayer AG has lost all three Roundup lawsuits it has taken to trial, with each jury finding that the plaintiffs’ exposure to glyphosate caused their diagnoses of Non-Hodgkin’s Lymphoma. Several additional trials that were scheduled for fall 2019 have been postponed to early 2020.

What Have The Roundup Trials Revealed?

In addition to juries finding that glyphosate can cause cancer, the Roundup trials have revealed questionable business practices by Monsanto—the original manufacturer of Roundup. Monsanto glyphosate-structure-chalkboardwas purchased by Bayer AG in 2018.

Documents produced at the trials have exposed that Monsanto engaged in “ghostwriting” research about glyphosate.  In other words, the company paid prominent scientists, researchers, and journalists to put their names on favorable research about glyphosate that was actually produced by Monsanto employees. Additionally, Monsanto allegedly lobbied for help from the Environmental Protection Agency (EPA) to hide a negative study of glyphosate that was released by the Department of Health and Human Services.

Bayer AG’s Legal Response

Bayer AG inherited massive litigation expenses with their acquisition of Monsanto for $63 billion in 2018. Since then, the Roundup crisis has already cost Bayer AG more than $30 billion in market value. Analysts have estimated that settling all of the U.S. Roundup lawsuits could cost anywhere between $2.5 billion to $20 billion. The company announced in July 2019 that it had begun mediation talks with Ken Feinburg to attempt to reach a settlement.

What Is Bayer Saying About Roundup Now?

Bayer AG continues to assert that Roundup is safe and that glyphosate is not carcinogenic. Therefore, the company has never considered pulling Roundup off the market despite the mounting allegations, research, and trial verdicts questioning its safety for consumers.

Bayer AG has been steadfast in refusing to add a warning label to Roundup products, issue a recall, or any outright discontinuance of the products containing glyphosate. However, that strategy comes with legal consequences. As long as the product continues to be sold without a warning label, the company is exposed to lawsuits linking ongoing Roundup use to future cancer diagnoses.

Despite refusing to remove Roundup from the market or add a warning label, Bayer AG announced in June 2019 that it was researching a glyphosate alternative at a cost of $5.6 billion.

What Are The Symptoms of Non-Hodgkin’s Lymphoma?  

Symptoms of Non-Hodgkin’s Lymphoma – the illness allegedly caused by use of Roundup exposure – include:

  • Painless, swollen lymph nodes in your neck, armpits, or groin;
  • Abdominal pain or swelling;
  • Chest pain, coughing or trouble breathing;
  • Persistent fatigue;
  • Fever;
  • Night sweats;
  • Unexplained weight loss 

What Should I Do Now?

If you or a loved one has been diagnosed with a form of Non-Hodgkin’s Lymphoma after Roundup use and/or exposure, please reach out to GoldenbergLaw’s Minnesota Roundup Cancer Attorneys. We will guide you through the legal process and fight to get you the compensation needed to help get your life back on track. Let us deliver the Gold standard advocacy you deserve.

Category Defective Products News Safety Information